title: Acute nonlymphocytic leukemia in adults: results obtained with TAD remission induction therapy.
authors.affiliation: Department of Hematology, University Hospital, Utrecht, The Netherlands.
authors.forename: E O
authors.initials: EO
authors.lastname: Witteveen
authors.forename: L F
authors.initials: LF
authors.lastname: Verdonck
authors.forename: H K
authors.initials: HK
authors.lastname: Nieuwenhuis
authors.forename: A W
authors.initials: AW
authors.lastname: Dekker
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004341:Drug Evaluation; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D015993:Life Tables; D008875:Middle Aged; D009426:Netherlands / Q000453:epidemiology; D012074:Remission Induction; D015996:Survival Rate; D013866:Thioguanine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D013866:Thioguanine; D003630:Daunorubicin